India · Delayed Price · Currency is INR Thyrocare Technologies Statistics
Total Valuation
NSE:THYROCARE has a market cap or net worth of INR 89.43 billion. The enterprise value is 88.05 billion.
| Market Cap | 89.43B |
| Enterprise Value | 88.05B |
Important Dates
The next confirmed earnings date is Thursday, July 23, 2026.
| Earnings Date | Jul 23, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
| Current Share Class | 159.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -1.34% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 23.05% |
| Float | 62.19M |
Valuation Ratios
The trailing PE ratio is 54.85 and the forward PE ratio is 44.84.
| PE Ratio | 54.85 |
| Forward PE | 44.84 |
| PS Ratio | 10.79 |
| PB Ratio | 15.26 |
| P/TBV Ratio | 18.88 |
| P/FCF Ratio | 46.49 |
| P/OCF Ratio | 41.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.45, with an EV/FCF ratio of 45.77.
| EV / Earnings | 54.00 |
| EV / Sales | 10.62 |
| EV / EBITDA | 33.45 |
| EV / EBIT | 42.92 |
| EV / FCF | 45.77 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.39 |
| Quick Ratio | 2.47 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | 0.26 |
| Interest Coverage | 72.78 |
Financial Efficiency
Return on equity (ROE) is 28.74% and return on invested capital (ROIC) is 38.33%.
| Return on Equity (ROE) | 28.74% |
| Return on Assets (ROA) | 17.69% |
| Return on Invested Capital (ROIC) | 38.33% |
| Return on Capital Employed (ROCE) | 31.97% |
| Weighted Average Cost of Capital (WACC) | 6.79% |
| Revenue Per Employee | 4.35M |
| Profits Per Employee | 855,404 |
| Employee Count | 1,906 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 7.34 |
Taxes
In the past 12 months, NSE:THYROCARE has paid 500.30 million in taxes.
| Income Tax | 500.30M |
| Effective Tax Rate | 23.50% |
Stock Price Statistics
The stock price has increased by +42.57% in the last 52 weeks. The beta is 0.47, so NSE:THYROCARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +42.57% |
| 50-Day Moving Average | 519.45 |
| 200-Day Moving Average | 448.20 |
| Relative Strength Index (RSI) | 59.90 |
| Average Volume (20 Days) | 428,593 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:THYROCARE had revenue of INR 8.29 billion and earned 1.63 billion in profits. Earnings per share was 10.21.
| Revenue | 8.29B |
| Gross Profit | 4.48B |
| Operating Income | 2.04B |
| Pretax Income | 2.13B |
| Net Income | 1.63B |
| EBITDA | 2.43B |
| EBIT | 2.04B |
| Earnings Per Share (EPS) | 10.21 |
Balance Sheet
The company has 1.90 billion in cash and 506.90 million in debt, with a net cash position of 1.39 billion.
| Cash & Cash Equivalents | 1.90B |
| Total Debt | 506.90M |
| Net Cash | 1.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.86B |
| Book Value Per Share | 36.79 |
| Working Capital | 2.62B |
Cash Flow
In the last 12 months, operating cash flow was 2.13 billion and capital expenditures -208.80 million, giving a free cash flow of 1.92 billion.
| Operating Cash Flow | 2.13B |
| Capital Expenditures | -208.80M |
| Depreciation & Amortization | 392.30M |
| Net Borrowing | -183.90M |
| Free Cash Flow | 1.92B |
| FCF Per Share | n/a |
Margins
Gross margin is 54.00%, with operating and profit margins of 24.58% and 19.67%.
| Gross Margin | 54.00% |
| Operating Margin | 24.58% |
| Pretax Margin | 25.68% |
| Profit Margin | 19.67% |
| EBITDA Margin | 29.31% |
| EBIT Margin | 24.58% |
| FCF Margin | 23.20% |
Dividends & Yields
This stock pays an annual dividend of 9.33, which amounts to a dividend yield of 1.79%.
| Dividend Per Share | 9.33 |
| Dividend Yield | 1.79% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 91.04% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 1.74% |
| Earnings Yield | 1.82% |
| FCF Yield | 2.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:THYROCARE is 603.00, which is 7.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 603.00 |
| Price Target Difference | 7.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 17.10% |
| EPS Growth Forecast (3Y) | 20.63% |
Stock Splits
The last stock split was on November 28, 2025. It was a forward split with a ratio of 3.
| Last Split Date | Nov 28, 2025 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
NSE:THYROCARE has an Altman Z-Score of 26.36 and a Piotroski F-Score of 7.
| Altman Z-Score | 26.36 |
| Piotroski F-Score | 7 |